BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 28451714)

  • 1. Diabetes, bone and glucose-lowering agents: clinical outcomes.
    Schwartz AV
    Diabetologia; 2017 Jul; 60(7):1170-1179. PubMed ID: 28451714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes, bone and glucose-lowering agents: basic biology.
    Lecka-Czernik B
    Diabetologia; 2017 Jul; 60(7):1163-1169. PubMed ID: 28434032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of diabetes and diabetes medications on bone health.
    Gilbert MP; Pratley RE
    Endocr Rev; 2015 Apr; 36(2):194-213. PubMed ID: 25738213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and bone fragility: a dangerous liaison.
    Conti F; Wolosinska DT; Pugliese G
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S39-41. PubMed ID: 23907773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture Risk Assessment in Patients With Diabetes Mellitus.
    Poiana C; Capatina C
    J Clin Densitom; 2017; 20(3):432-443. PubMed ID: 28716499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiabetic therapy effects on bone metabolism and fracture risk.
    Montagnani A; Gonnelli S
    Diabetes Obes Metab; 2013 Sep; 15(9):784-91. PubMed ID: 23368527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus.
    Blevins TC; Farooki A
    Postgrad Med; 2017 Jan; 129(1):159-168. PubMed ID: 27894216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antidiabetic treatment on bone.
    Jackuliak P; Kužma M; Payer J
    Physiol Res; 2019 Nov; 68(Suppl 2):S107-S120. PubMed ID: 31842574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone disorders associated with diabetes mellitus and its treatments.
    Cortet B; Lucas S; Legroux-Gerot I; Penel G; Chauveau C; Paccou J
    Joint Bone Spine; 2019 May; 86(3):315-320. PubMed ID: 30098423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes and the skeleton: new insights into sweet bones.
    Shanbhogue VV; Mitchell DM; Rosen CJ; Bouxsein ML
    Lancet Diabetes Endocrinol; 2016 Feb; 4(2):159-73. PubMed ID: 26365605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone loss and fracture risk associated with thiazolidinedione therapy.
    Riche DM; King ST
    Pharmacotherapy; 2010 Jul; 30(7):716-27. PubMed ID: 20575635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fracture Patterns in Type 1 and Type 2 Diabetes Mellitus: A Narrative Review of Recent Literature.
    Van Hulten V; Rasmussen N; Driessen JHM; Burden AM; Kvist A; van den Bergh JP
    Curr Osteoporos Rep; 2021 Dec; 19(6):644-655. PubMed ID: 34931295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 diabetes mellitus and fracture risk.
    Dede AD; Tournis S; Dontas I; Trovas G
    Metabolism; 2014 Dec; 63(12):1480-90. PubMed ID: 25284729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of glucose-lowering drugs and risk of fracture in patients with type 2 diabetes.
    Starup-Linde J; Gregersen S; Frost M; Vestergaard P
    Bone; 2017 Feb; 95():136-142. PubMed ID: 27890548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone metabolism in type 2 diabetes and role of thiazolidinediones.
    Vestergaard P
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):125-31. PubMed ID: 19300092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes medications and bone.
    Grey A
    Curr Osteoporos Rep; 2015 Feb; 13(1):35-40. PubMed ID: 25433437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetes mellitus and osteoporosis. Effect of antidiabetic medicine on osteoporotic fracture].
    Hayakawa N; Suzuki A
    Clin Calcium; 2012 Sep; 22(9):1383-90. PubMed ID: 22932293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Do thiazolidinediones harm skeletal integrity?].
    Takeuchi Y
    Clin Calcium; 2008 May; 18(5):650-5. PubMed ID: 18445884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes pharmacotherapy and effects on the musculoskeletal system.
    Kalaitzoglou E; Fowlkes JL; Popescu I; Thrailkill KM
    Diabetes Metab Res Rev; 2019 Feb; 35(2):e3100. PubMed ID: 30467957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of diabetes therapy on bone: A clinical perspective.
    Kheniser KG; Polanco Santos CM; Kashyap SR
    J Diabetes Complications; 2018 Jul; 32(7):713-719. PubMed ID: 29747995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.